Effects of viral hemorrhagic fever inactivation methods on the performance of rapid diagnostic tests for Plasmodium falciparum

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1852-1855

  Loutfy, Mona R ^c   Assmar, Mehdi ^a   Burgess, Deborah C Hay ^c   Kain, Kevin C ^b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; LABORATORY INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RISK MANAGEMENT; VIRUS HEMORRHAGIC FEVER;

BLOOD; BLOOD SPECIMEN COLLECTION; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; GAMMA RAYS; HEAT; HEMORRHAGIC FEVERS, VIRAL; HUMANS; MALARIA, FALCIPARUM; METHANOL; OCTOXYNOL; REAGENT STRIPS;

EID: 0031736860     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314524     Document Type: Article

References (5)

1. Centers for Disease Control. Management of patients with suspected viral hemorrhagic fever. MMWR 1988;37:1-15.
2. Laboratory Centre for Disease Control. Canadian contingency plan for viral hemorrhagic fevers and other related diseases. Can Commun Dis Rep 1997;23:1-13.
3. Rollin PE, Ksiazek TG. Ebola haemorrhagic fever. Trans R Soc Trop Med Hyg 1998;92:l-2.
4. Breman JG, van der Groen G, Peters CJ, Heymann DL. International colloquium on Ebola virus research: summary report. J Infect Dis 1997;176: 1058-63.
5. Clayton AJ. Lassa fever, Marburg and Ebola virus diseases and other exotic diseases: is there a risk to Canada? Can Med Assoc J 1979;120: 146-55.